4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-012336
President & CEO sold 108,882 shares at an average $42.19 ($4,594,176)
- President & CEO acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2019-02-19 | Option exercise | +33,333 | $7.21 | $240,331 | 350,924 | D |
| ROBIN HOWARD W President & CEO | 2019-02-19 | Sale | −33,333 | $42.32 | $1,410,653 | 317,591 | D |
| ROBIN HOWARD W President & CEO | 2019-02-19 | Sale | −8,882 | $42.39 | $376,508 | 308,709 | D |
| ROBIN HOWARD W President & CEO | 2019-02-20 | Option exercise | +33,334 | $7.21 | $240,338 | 342,043 | D |
| ROBIN HOWARD W President & CEO | 2019-02-20 | Sale | −33,334 | $43.20 | $1,440,029 | 308,709 | D |
| ROBIN HOWARD W President & CEO | 2019-02-21 | Option exercise | +33,333 | $7.21 | $240,331 | 342,042 | D |
| ROBIN HOWARD W President & CEO | 2019-02-21 | Sale | −33,333 | $41.01 | $1,366,986 | 308,709 | D |
| Derivatives | |||||||
| ROBIN HOWARD W President & CEO | 2019-02-19 | Option exercise · Common Stock | −33,333 | 166,667 | D | ||
| ROBIN HOWARD W President & CEO | 2019-02-20 | Option exercise · Common Stock | −33,334 | 133,333 | D | ||
| ROBIN HOWARD W President & CEO | 2019-02-21 | Option exercise · Common Stock | −33,333 | 100,000 | D | ||
| Open-market sales · 108,882 sh · avg $42.19 · $4,594,176 | |||||||
Loading xslF345X03/doc4.xml…